XOLAIR (OMALIZUMAB) — FDA Approval BLA103976 (GENENTECH)
XOLAIR (OMALIZUMAB) — FDA Approval BLA103976 (GENENTECH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: XOLAIR; Active ingredients: OMALIZUMAB; Application number: BLA103976.
| Brand name | XOLAIR |
|---|---|
| Active ingredients | OMALIZUMAB |
| Application number | BLA103976 |
| Sponsor | GENENTECH |
| Dosage form | VIAL |
| Marketing status | Prescription |
| Products in application | 4 |
| First approval date | 20030620 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →